Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. FWP Offering Free Writing Prospectus
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. 144 Insider Sale of Securities
  7. EFFECT Other Notice of Effectiveness
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. EFFECT Other Notice of Effectiveness
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 144 Insider Sale of Securities
  13. EFFECT Other Notice of Effectiveness
  14. ARS Other Annual Report to Security Holders
  15. DEFA14A Proxy Proxy Materials
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. POSASR Other POSASR
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 1 of 4 · 73 filings